238 related articles for article (PubMed ID: 11401583)
61. Mast Cell β-Tryptase Is Enzymatically Stabilized by DNA.
Alanazi S; Grujic M; Lampinen M; Rollman O; Sommerhoff CP; Pejler G; Melo FR
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709152
[TBL] [Abstract][Full Text] [Related]
62. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
Stevens RL; Adachi R
Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058
[TBL] [Abstract][Full Text] [Related]
63. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
[TBL] [Abstract][Full Text] [Related]
64. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.
Caughey GH; Raymond WW; Blount JL; Hau LW; Pallaoro M; Wolters PJ; Verghese GM
J Immunol; 2000 Jun; 164(12):6566-75. PubMed ID: 10843716
[TBL] [Abstract][Full Text] [Related]
65. Dual functionality of β-tryptase protomers as both proteases and cofactors in the active tetramer.
Maun HR; Liu PS; Franke Y; Eigenbrot C; Forrest WF; Schwartz LB; Lazarus RA
J Biol Chem; 2018 Jun; 293(25):9614-9628. PubMed ID: 29661938
[TBL] [Abstract][Full Text] [Related]
66. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition.
Stubbs MT; Morenweiser R; Stürzebecher J; Bauer M; Bode W; Huber R; Piechottka GP; Matschiner G; Sommerhoff CP; Fritz H; Auerswald EA
J Biol Chem; 1997 Aug; 272(32):19931-7. PubMed ID: 9242660
[TBL] [Abstract][Full Text] [Related]
67. Mast cell tryptase: hoisted by its own petard?
Caughey GH
J Clin Invest; 1996 Feb; 97(4):895-6. PubMed ID: 8613539
[No Abstract] [Full Text] [Related]
68. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
69. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities.
Pang L; Nie M; Corbett L; Sutcliffe A; Knox AJ
J Immunol; 2006 Mar; 176(6):3788-95. PubMed ID: 16517749
[TBL] [Abstract][Full Text] [Related]
70. The human mast cell tryptase tetramer: a fascinating riddle solved by structure.
Sommerhoff CP; Bode W; Matschiner G; Bergner A; Fritz H
Biochim Biophys Acta; 2000 Mar; 1477(1-2):75-89. PubMed ID: 10708850
[TBL] [Abstract][Full Text] [Related]
71. Mast cell tryptase activates extracellular-regulated kinases (p44/p42) in airway smooth-muscle cells: importance of proteolytic events, time course, and role in mediating mitogenesis.
Brown JK; Jones CA; Rooney LA; Caughey GH
Am J Respir Cell Mol Biol; 2001 Feb; 24(2):146-54. PubMed ID: 11159048
[TBL] [Abstract][Full Text] [Related]
72. Expression and characterization of recombinant mast cell tryptase.
Chan H; Elrod KC; Numerof RP; Sideris S; Clark JM
Protein Expr Purif; 1999 Apr; 15(3):251-7. PubMed ID: 10092484
[TBL] [Abstract][Full Text] [Related]
73. pH dependence of bovine mast cell tryptase catalytic activity and of its inhibition by 4',6-diamidino-2-phenylindole.
Fiorucci L; Erba F; Bolognesi M; Coletta M; Ascoli F
FEBS Lett; 1997 May; 408(1):85-8. PubMed ID: 9180274
[TBL] [Abstract][Full Text] [Related]
74. Regulation of the activity of secreted human lung mast cell tryptase by mast cell proteoglycans.
Lindstedt KA; Kokkonen JO; Kovanen PT
Biochim Biophys Acta; 1998 Nov; 1425(3):617-27. PubMed ID: 9838225
[TBL] [Abstract][Full Text] [Related]
75. Mast cell tryptases and airway remodeling.
Sommerhoff CP
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S52-8. PubMed ID: 11734467
[TBL] [Abstract][Full Text] [Related]
76. Molecular cloning of dog mast cell tryptase and a related protease: structural evidence of a unique mode of serine protease activation.
Vanderslice P; Craik CS; Nadel JA; Caughey GH
Biochemistry; 1989 May; 28(10):4148-55. PubMed ID: 2504277
[TBL] [Abstract][Full Text] [Related]
77. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
Rice KD; Gangloff AR; Kuo EY; Dener JM; Wang VR; Lum R; Newcomb WS; Havel C; Putnam D; Cregar L; Wong M; Warne RL
Bioorg Med Chem Lett; 2000 Oct; 10(20):2357-60. PubMed ID: 11055355
[TBL] [Abstract][Full Text] [Related]
78. The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.
Sommerhoff CP; Bode W; Pereira PJ; Stubbs MT; Stürzebecher J; Piechottka GP; Matschiner G; Bergner A
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):10984-91. PubMed ID: 10500112
[TBL] [Abstract][Full Text] [Related]
79. Synthesis of potent and highly selective inhibitors of human tryptase.
Slusarchyk WA; Bolton SA; Hartl KS; Huang MH; Jacobs G; Meng W; Ogletree ML; Pi Z; Schumacher WA; Seiler SM; Sutton JC; Treuner U; Zahler R; Zhao G; Bisacchi GS
Bioorg Med Chem Lett; 2002 Nov; 12(21):3235-8. PubMed ID: 12372541
[TBL] [Abstract][Full Text] [Related]
80. Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2.
Asano-Kato N; Fukagawa K; Okada N; Dogru M; Tsubota K; Fujishima H
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4622-6. PubMed ID: 16303958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
